Company: SCLXW
Filing Date: 2025-01-17
Form Type: 424B3
Source: 0000950170-25-006777
Chunk: 90

Company: Scilex Holding Co
Filing Date: 2025-01-17
Form: 424B3
Chunk 90
---
 |       7 |   |     |         |      39 |   |
| Total other expense, net                               |     |                                  | (15,529 | ) |     |      |  (3,276 | ) |     |         | (12,253 | ) |
| Loss before income taxes                               |     |                                  |  (4,388 | ) |     |      | (35,529 | ) |     |         |  31,141 |   |
| Income tax benefit                                     |     |                                  |       — |   |     |      |       — |   |     |         |       0 |   |
| Net loss                                               |     | $                                |  (4,388 | ) |     | $    | (35,529 | ) |     | $       |  31,141 |   |

Comparison of the Three Months Ended September 30, 2024 and 2023

Net Revenue

Net revenue for the three months ended September 30, 2024 and 2023 was $14.4 million and $10.1 million, respectively. The increase of$4.3 millionwas driven by the increase in gross product sales of ELYXYB by approximately 54% driven by an increase in the sales volume and a standard industry annual price increase,and sales of GLOPERBA commencing in June 2024, partiallyoffset by an increase in rebates.

Cost of Revenue

Cost of revenue for the three months ended September 30, 2024 and 2023 was $3.8 million and $3.4 million, respectively. The increase of $0.4 million was primarily due to an increase in gross revenue of ELYXYB and GLOPERBA, partially offset by a decrease in logistics costs due to no air shipments used during the three months ended September 30, 2024 compared to the three months ended September 30, 2023.

Research and Development Expenses

The following table summarizes research and development expenses by project for the three months ended September 30, 2024 and 2023 (in thousands):

<div align='center'>47</div>

| SP-102                                  |     | Three Months Ended September 30, 
 2024                             |       |   |     | 2023 |       |     | Increase   
 (Decrease) |        |   |
|:----------------------------------------|:----|:---------------------------------|------:|:--|